Abreos Biosciences Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
6
- Latest Deal Type
-
M&A
Abreos Biosciences General Information
Description
Developer of peptide antigen mimetics technology designed to improve the development and commercialization of biopharmaceuticals. The company's platform is laboratory-based and point-of-care assays that enable precision dosing and counterfeit detection of biologic drugs as well as permits for direct monitoring of blood concentrations of monoclonal antibody drugs for dosage, enabling medical professionals to rapidly authenticate for counterfeit prevention and end-user confidence.
Contact Information
Website
www.abreos.comCorporate Office
- 2223 Avenida de la Playa
- Suite 206
- La Jolla, CA 92037
- United States
Corporate Office
- 2223 Avenida de la Playa
- Suite 206
- La Jolla, CA 92037
- United States
Abreos Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Merger/Acquisition | 25-Jan-2021 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 8. Seed Round | 15-Sep-2020 | Completed | Generating Revenue | |||
| 7. Grant | 01-Jan-2020 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Jun-2017 | Completed | Generating Revenue | |||
| 5. Seed Round | 28-Jun-2016 | Completed | Generating Revenue | |||
| 4. Seed Round | 29-Mar-2016 | Cancelled | Generating Revenue | |||
| 3. Grant | 25-Sep-2015 | Completed | Generating Revenue | |||
| 2. Grant | 23-Sep-2014 | $371K | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | 01-Jan-2014 | Completed | Generating Revenue |
Abreos Biosciences Comparisons
Industry
Financing
Details
Abreos Biosciences Competitors (15)
One of Abreos Biosciences’s 15 competitors is Novus Biologicals, a Formerly PE-Backed company based in Centennial, CO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novus Biologicals | Formerly PE-Backed | Centennial, CO | ||||
| Proteintech | Corporation | Rosemont, IL | ||||
| ProSci (Poway) | Private Equity-Backed | Poway, CA | ||||
| Vividion Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Lycia Therapeutics | Venture Capital-Backed | South San Francisco, CA |
Abreos Biosciences Patents
Abreos Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4487123-A2 | Methods and compositions for measuring serum analyte levels from biological matrices | Pending | 02-Mar-2022 | ||
| US-20180291059-A1 | Immunoaffinity purification of antibodies using mimetopes | Inactive | 04-Apr-2017 | ||
| EP-3606937-A1 | Immunoaffinity purification of antibodies using mimetopes | Inactive | 04-Apr-2017 | ||
| EP-3606937-A4 | Immunoaffinity purification of antibodies using mimetopes | Inactive | 04-Apr-2017 | ||
| US-20210285959-A1 | Detection and quantification of natalizumab | Active | 12-Aug-2016 | G01N33/6854 |
Abreos Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Abreos Biosciences Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Blackbird Ventures (La Jolla) | Venture Capital | Minority | ||
| Keshif Ventures | Venture Capital | Minority | ||
| MedTech Innovator | Accelerator/Incubator | |||
| National Cancer Institute | Government | |||
| National Institute for Allergy and Infectious Disease | Government |
Abreos Biosciences Investments (1)
Abreos Biosciences’s most recent deal was a Joint Venture with Magnasense. The deal was made on 27-Nov-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Magnasense | 27-Nov-2019 | Joint Venture | Monitoring Equipment |
Abreos Biosciences FAQs
-
When was Abreos Biosciences founded?
Abreos Biosciences was founded in 2013.
-
Where is Abreos Biosciences headquartered?
Abreos Biosciences is headquartered in La Jolla, CA.
-
What is the size of Abreos Biosciences?
Abreos Biosciences has 6 total employees.
-
What industry is Abreos Biosciences in?
Abreos Biosciences’s primary industry is Biotechnology.
-
Is Abreos Biosciences a private or public company?
Abreos Biosciences is a Private company.
-
What is Abreos Biosciences’s current revenue?
The current revenue for Abreos Biosciences is .
-
How much funding has Abreos Biosciences raised over time?
Abreos Biosciences has raised $8.44M.
-
Who are Abreos Biosciences’s investors?
Blackbird Ventures (La Jolla), Keshif Ventures, MedTech Innovator, National Cancer Institute, and National Institute for Allergy and Infectious Disease are 5 of 11 investors who have invested in Abreos Biosciences.
-
Who are Abreos Biosciences’s competitors?
Novus Biologicals, Proteintech, ProSci (Poway), Vividion Therapeutics, and Lycia Therapeutics are some of the 15 competitors of Abreos Biosciences.
-
When was Abreos Biosciences acquired?
Abreos Biosciences was acquired on 25-Jan-2021.
-
Who acquired Abreos Biosciences?
Abreos Biosciences was acquired by Magnasense.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
